MedTrace Logo

Alexis Retractor in Total Hip Arthroplasty

NCT07237737 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2026-02-05

No results posted yet for this study

Summary

To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.

Conditions

  • Hip Osteoarthritis
  • Hip Arthritis

Interventions

DEVICE

Alexis wound retractor

A surgical device used to retract tissue during procedures, designed to reduce wound trauma and improve healing

DEVICE

Standard wound retractor

A conventional surgical retractor used during procedures without the features of the Alexis device

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Victor H Hernandez, MD, MSc · University of Miami Department of Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-31
Primary Completion
2028-01-31
Completion
2028-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07237737 on ClinicalTrials.gov